November is American Diabetes Month – an important time when communities across the country and around the globe come together to bring awareness to diabetes. Throughout this month, it is important to recognize the critical role biopharmaceutical innovation has played – and continues to play – in transforming diabetes care. Diabetes is a complex, chronic condition that affects each patient differently and is often related to a range of other chronic illnesses, requiring a diverse range of treatment options.